Dr Pallàs participated in UBNeuro Scientific Advisory Board meeting, in a round table about techtranfer and the experience acquired by the group in the las 10 years, presenting soluble epoxide hydrolase and G9a histone methyltransferase inhibitors related with research projects
PID2022-139016OA /AEI/ 10.13039/501100011033 to C. Griñán Ferre;
PID2022-13809OB-100/AEI/10. 13039/501100011033 to M. Pallàs
Se ofrece un contrato predoctoral, asociado al proyecto DESCODIFICACION Y MODULACION DE LOS RECEPTORES IMIDAZOLICOS I2: LIGANDOS MODULADORES PARA LA…
Prof. Diego Muñoz-Torrero served as Session Chair at the 5th Molecules Medicinal Chemistry Symposium (MMCS 2026): New Trends in Chemical…
Members of the Medicinal Chemistry and Pharmacology (MCP) group took part in the SEQT Young Researchers Symposium, organized by the…
The Medicinal Chemistry and Pharmacology (MCP) group participated in the X SEQT Summer School, Medicinal Chemistry and Chemical Biology in…
